Section: Avian Bacteria

Avian Pathogenic Escherichia coli (APEC) Infection in Poultry: Pathogenesis, Diagnostics, and Control

Introduction

Avian Pathogenic Escherichia coli (APEC) is the etiological agent of colibacillosis, a complex and economically devastating disease affecting poultry worldwide. Colibacillosis encompasses a spectrum of localized and systemic infections, including airsacculitis, pericarditis, perihepatitis, salpingitis, omphalitis, and cellulitis. APEC strains belong to the extraintestinal pathogenic E. coli (ExPEC) pathotype and are distinguished from commensal E. coli by the presence of specific virulence-associated genes (VAGs) that enable colonization of the avian respiratory tract, evasion of host immune defenses, and dissemination to internal organs [1, 2]. The disease is a primary cause of morbidity, mortality, and carcass condemnation in broiler, layer, and breeder flocks, resulting in substantial economic losses to the poultry industry [3].

APEC infections are frequently secondary to immunosuppressive conditions or concurrent viral infections, such as those caused by Infectious Bursal Disease Virus variants or Avian Influenza A(H5N1) in Poultry and Wild Birds: Current Epidemiology, Molecular Diagnostics, and Biosecurity. The emergence of multidrug-resistant (MDR) APEC strains has further complicated treatment and control, underscoring the need for robust biosecurity protocols, effective vaccines, and advanced molecular diagnostic tools [4, 5].

Virulence Factors and Pathogenesis

APEC pathogenicity is multifactorial, relying on a repertoire of VAGs that mediate adhesion, iron acquisition, toxin production, and serum resistance. These genes are often located on large plasmids, pathogenicity islands (PAIs), or integrated into the chromosome [6].

Adhesins and Fimbriae

Adhesion to host epithelial cells is the initial step in APEC infection. Type 1 fimbriae (Fim) mediate binding to mannose-containing receptors on respiratory epithelial cells. The fim operon is highly conserved among E. coli strains, but APEC strains often express additional fimbrial types, including P fimbriae (Pap), S fimbriae (Sfa), and F17-like fimbriae, which enhance tropism for extraintestinal sites [7, 8]. The pap operon encodes pyelonephritis-associated pili that bind to globoside receptors on avian tissues. The yqi operon, encoding a putative fimbrial adhesin, has also been associated with APEC virulence [9].

Iron Acquisition Systems

Iron is an essential cofactor for bacterial metabolism and is sequestered by host proteins such as transferrin and lactoferrin. APEC strains possess multiple high-affinity iron acquisition systems to overcome this nutritional limitation. The aerobactin siderophore system (encoded by iucABCD and iutA) is a hallmark of APEC and is strongly associated with virulence [10]. The salmonchelin system (iroBCDEN) and the yersiniabactin system (fyuA and irp2) are also prevalent among APEC isolates [11]. These systems enable APEC to scavenge iron from the host environment, facilitating bacterial proliferation in serum and internal organs.

Toxins

APEC strains produce several toxins that contribute to tissue damage and immune evasion. Hemolysin (HlyA) is a pore-forming cytotoxin that lyses erythrocytes and nucleated cells. The hlyA gene is more commonly associated with uropathogenic E. coli (UPEC) but is present in a subset of APEC strains [12]. Vacuolating autotransporter toxin (Vat) is a serine protease autotransporter that induces vacuolation in host cells and is encoded by the vat gene, which is enriched in APEC compared to commensal strains [13]. Cytotoxic necrotizing factor 1 (CNF1) and cytolethal distending toxin (CDT) have also been identified in APEC isolates [14].

Serum Resistance and Immune Evasion

Resistance to complement-mediated killing is a critical determinant of APEC systemic spread. The outer membrane protein TraT, encoded by the traT gene, inhibits complement activation. The iss (increased serum survival) gene, originally described in a neonatal meningitis E. coli strain, is highly prevalent in APEC and confers resistance to both complement and phagocytosis [15]. The K1 capsular polysaccharide, encoded by the neu operon, provides additional protection against phagocytosis and complement deposition [16].

Lipopolysaccharide (LPS) and Flagella

The O-antigen component of LPS is a major virulence factor that contributes to serum resistance and induces a strong inflammatory response. APEC strains are predominantly associated with O1, O2, O18, and O78 serogroups [17]. Flagella-mediated motility, encoded by the fliC gene, facilitates bacterial translocation across mucosal barriers and is associated with invasiveness in APEC [18].

Clinical Signs and Pathological Findings

The clinical presentation of APEC infection varies depending on the age of the bird, the route of infection, and the presence of predisposing factors.

Broilers

In broilers, colibacillosis typically manifests as a respiratory disease complex, often following infection with respiratory viruses such as Avian Influenza A(H5N1) in Poultry and Wild Birds: Current Epidemiology, Molecular Diagnostics, and Biosecurity or Mycoplasma gallisepticum. Clinical signs include depression, ruffled feathers, reduced feed intake, and respiratory distress characterized by gasping and coughing. Mortality can reach 5-20% in affected flocks [19].

Gross pathological findings include fibrinous airsacculitis, pericarditis, and perihepatitis. The liver and heart are often covered by a thick, yellow-white fibrinous exudate. In severe cases, fibrinous polyserositis extends to the peritoneum. Cellulitis, characterized by subcutaneous fibrino-necrotic plaques on the abdomen and thighs, is a common cause of carcass condemnation at processing [20].

Layers

In laying hens, APEC frequently causes salpingitis and peritonitis. The infection ascends from the cloaca or descends from the respiratory tract. Affected hens exhibit a sudden drop in egg production, lethargy, and a hunched posture. Post-mortem examination reveals a distended oviduct filled with fibrino-purulent exudate, often accompanied by egg-yolk peritonitis. Chronic salpingitis can lead to egg binding and death [21].

Young Poults

Omphalitis (yolk sac infection) occurs in chicks and poults within the first week of life. Infection is acquired through contamination of the egg shell or hatchery environment. Clinical signs include lethargy, failure to thrive, and a swollen, unhealed navel. The yolk sac appears thickened, discolored, and malodorous. Mortality can be high in untreated flocks [22].

Diagnostic Approaches

Accurate diagnosis of APEC infection requires a combination of clinical observation, necropsy, and laboratory confirmation. The following table summarizes the primary diagnostic methods.

| Diagnostic Method | Target | Advantages | Limitations | | :-, | :-, | :-, | :-, | | Bacterial Culture | Viable E. coli from lesions | Gold standard; isolates available for AST | Requires 24-48 hours; cannot differentiate APEC from commensals | | Serotyping | O and K antigens | Epidemiological typing; identifies high-risk serogroups | Limited serogroup coverage; cross-reactivity | | Conventional PCR | VAGs (e.g., iss, iutA, hlyF, iroN, ompT) | Rapid; high sensitivity; differentiates APEC from commensals | Requires DNA extraction; multiplex optimization needed | | Quantitative PCR (qPCR) | VAGs; bacterial load | Quantifies bacterial burden; high throughput | Higher cost; requires standard curve | | Multiplex PCR | Panel of VAGs | Simultaneous detection of multiple virulence markers | Primer design complexity; potential for amplicon competition | | Whole Genome Sequencing (WGS) | Complete genome; MLST; serogroup prediction | Definitive typing; AMR gene detection; phylogenetic analysis | High cost; bioinformatics expertise required | | ELISA | Serum antibodies | Serological surveillance; vaccine response monitoring | Cannot distinguish current from past infection; cross-reactivity | | Histopathology | Tissue lesions | Confirms fibrinous inflammation; rule out other pathogens | Non-specific; requires specialized training |

Bacterial Culture and Isolation

Samples for culture should be collected aseptically from lesions (e.g., liver, spleen, pericardial sac, air sacs, yolk sac) using sterile swabs or tissue biopsies. Samples are plated on MacConkey agar and incubated aerobically at 37 degrees Celsius for 18-24 hours. Lactose-fermenting colonies (pink on MacConkey) are presumptively identified as E. coli and confirmed by biochemical tests (e.g., indole production, methyl red, Voges-Proskauer, citrate utilization) or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) [23].

Serotyping

Serotyping based on O (lipopolysaccharide) and K (capsular) antigens is performed using agglutination with specific antisera. The most common APEC serogroups are O1, O2, O18, and O78. However, serotyping has limited discriminatory power and cannot reliably distinguish APEC from commensal strains [24].

Molecular Diagnostics: PCR and Sequencing

Polymerase chain reaction (PCR) targeting VAGs is the most widely used method for APEC identification. A commonly used multiplex PCR panel targets five genes: iss (increased serum survival), iutA (aerobactin receptor), hlyF (hemolysin F), iroN (salmochelin receptor), and ompT (outer membrane protease). The presence of two or more of these genes is strongly predictive of APEC status [25, 26].

Quantitative PCR (qPCR) allows for the quantification of bacterial load in tissues and can be used to monitor the progression of infection. Real-time PCR assays targeting the uidA gene (beta-glucuronidase) are used for generic E. coli detection, while APEC-specific qPCR assays target VAGs such as iss [27].

Whole genome sequencing (WGS) provides the highest resolution for APEC characterization. WGS enables in silico serotyping, multilocus sequence typing (MLST), detection of AMR genes and virulence determinants, and phylogenetic analysis. Core genome MLST (cgMLST) is increasingly used for outbreak investigations and epidemiological surveillance [28, 29].

Serological Assays

Enzyme-linked immunosorbent assays (ELISAs) for APEC are used primarily for serological surveillance and vaccine efficacy studies. Commercial ELISA kits detect antibodies against O-antigens or whole-cell antigens. However, serology cannot distinguish between vaccinated and infected birds and has limited utility for individual diagnosis [30].

Antimicrobial Resistance

Antimicrobial resistance (AMR) in APEC is a growing concern. APEC isolates frequently exhibit resistance to multiple drug classes, including tetracyclines, sulfonamides, beta-lactams, aminoglycosides, and fluoroquinolones [31]. Resistance is mediated by a variety of mechanisms, including enzymatic degradation (e.g., beta-lactamases such as TEM, SHV, CTX-M), target modification (e.g., gyrA mutations for fluoroquinolone resistance), efflux pumps (e.g., AcrAB-TolC), and plasmid-mediated resistance genes (e.g., tet genes for tetracycline resistance, sul genes for sulfonamide resistance) [32, 33].

The high prevalence of MDR APEC is driven by the widespread use of antibiotics in poultry production for prophylaxis, metaphylaxis, and growth promotion. The emergence of extended-spectrum beta-lactamase (ESBL)-producing APEC strains, particularly those carrying blaCTX-M genes, poses a significant threat to both animal and human health due to the potential for zoonotic transmission of resistance determinants [34]. For a broader discussion of AMR in livestock pathogens, see Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.

Control and Prevention

Control of APEC infection relies on an integrated approach combining biosecurity, management practices, vaccination, and judicious antimicrobial use.

Biosecurity and Management

Biosecurity measures are the first line of defense against APEC introduction and spread. Key measures include:

  • All-in/all-out production systems to break the cycle of infection.
  • Strict sanitation of housing, equipment, and water lines.
  • Control of rodent and insect vectors.
  • Litter management to reduce ammonia levels and dust, which predispose birds to respiratory disease.
  • Optimal ventilation and temperature control.
  • Hatchery hygiene, including egg disinfection and fumigation, to prevent vertical transmission [35].

Vaccination

Vaccination is a critical component of APEC control. Both autogenous (farm-specific) and commercial vaccines are available. Vaccine formulations include:

  • Bacterins: Inactivated whole-cell vaccines that induce humoral immunity against homologous serogroups. They are commonly used in breeders to provide passive immunity to progeny via maternal antibodies [36].
  • Live attenuated vaccines: Strains with deletions in virulence genes (e.g., aroA, galE) that induce both humoral and cell-mediated immunity. They offer broader cross-protection than bacterins but carry a risk of reversion to virulence [37].
  • Subunit vaccines: Recombinant proteins targeting conserved virulence factors such as the aerobactin receptor (IutA), the outer membrane protease (OmpT), or the iron-regulated protein (IroN). These vaccines aim to provide broad protection across multiple serogroups [38, 39].
  • Vector vaccines: Recombinant viruses (e.g., fowlpox virus, Newcastle disease virus) expressing APEC antigens are under development [40].

The following Mermaid diagram illustrates a decision tree for APEC vaccination strategy selection.

flowchart TD
    A[APEC Vaccination Decision], > B{Flock Type}
    B, >|Broiler Breeders| C[Use autogenous or commercial bacterin]
    B, >|Layers| D[Consider live attenuated or subunit vaccine]
    B, >|Broilers| E[Evaluate maternal antibody levels]
    C, > F[Administer in rearing period]
    D, > G[Administer during lay]
    E, >|Low maternal antibodies| H[Consider live vaccine in day-old chicks]
    E, >|High maternal antibodies| I[Delay vaccination]
    F, > J[Monitor serological response]
    G, > J
    H, > J
    I, > J
    J, > K[Assess field challenge and adjust program]

Antimicrobial Therapy

Antimicrobial therapy should be guided by culture and antimicrobial susceptibility testing (AST) to minimize the selection of resistance. Commonly used antimicrobials include amoxicillin, florfenicol, enrofloxacin, and trimethoprim-sulfamethoxazole. However, due to high levels of resistance, empirical therapy is increasingly unreliable. Alternatives such as bacteriophages, bacteriocins, and organic acids are being investigated as adjuncts or replacements for conventional antibiotics [41, 42].

Probiotics and Prebiotics

Probiotics (e.g., Lactobacillus, Bifidobacterium, Bacillus species) and prebiotics (e.g., mannan-oligosaccharides, fructo-oligosaccharides) can modulate the gut microbiota, enhance mucosal immunity, and reduce intestinal colonization by APEC. Their inclusion in feed or water has shown variable efficacy in reducing colibacillosis incidence [43, 44].

Zoonotic Considerations

APEC strains are genetically related to human ExPEC strains, including those causing neonatal meningitis and urinary tract infections. The potential for zoonotic transmission of APEC or its resistance genes through the food chain is a public health concern. Comparative genomic studies have identified shared virulence genes and phylogenetic clades between APEC and human ExPEC, suggesting that poultry may serve as a reservoir for human extraintestinal infections [45, 46]. This highlights the importance of a One Health approach to APEC surveillance and control.

Future Directions

Advances in genomics, bioinformatics, and immunology are driving the development of next-generation APEC control strategies. Key areas of research include:

  • Pan-genome analysis: Identification of novel vaccine targets conserved across diverse APEC lineages [47].
  • CRISPR-based antimicrobials: Sequence-specific killing of MDR APEC strains [48].
  • Machine learning models: Prediction of APEC virulence and AMR profiles from genomic data [49].
  • Metagenomic surveillance: Monitoring APEC diversity and resistance gene dissemination in poultry production environments [50].

References

[1] Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res. 1999;30(2-3):299-316.

[2] Johnson TJ, Wannemuehler Y, Doetkott C, Johnson SJ, Rosenberger SC, Nolan LK. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol. 2008;46(12):3987-3996.

[3] Ewers C, Janssen T, Wieler LH. Avian pathogenic Escherichia coli (APEC). Berl Munch Tierarztl Wochenschr. 2003;116(9-10):381-395.

[4] Mellata M. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis. 2013;10(11):916-932.

[5] Collignon P, McEwen S. One Health: its importance in helping to better control antimicrobial resistance. Trop Med Infect Dis. 2019;4(1):22.

[6] Johnson TJ, Nolan LK. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev. 2009;73(4):750-774.

[7] La Ragione RM, Woodward MJ. Virulence factors of Escherichia coli serotypes associated with avian colisepticaemia. Res Vet Sci. 2002;73(1):27-35.

[8] Dozois CM, Dho-Moulin M, Bree A, Fairbrother JM, Desautels C, Curtiss R 3rd. Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the tsh genetic region. Infect Immun. 2000;68(7):4145-4154.

[9] Antao EM, Wieler LH, Ewers C. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog. 2009;1(1):22.

[10] Garenaux A, Caza M, Dozois CM. The Ins and Outs of siderophore mediated iron uptake by extra-intestinal pathogenic Escherichia coli. Vet Microbiol. 2011;153(1-2):89-98.

[11] Caza M, Lepine F, Dozois CM. Secretion, but not overall synthesis, of catecholate siderophores contributes to virulence of extraintestinal pathogenic Escherichia coli. Mol Microbiol. 2011;80(1):266-282.

[12] Ewers C, Li G, Wilking H, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int J Med Microbiol. 2007;297(3):163-176.

[13] Parreira VR, Gyles CL. A novel pathogenicity island integrated adjacent to the thrW tRNA gene of avian pathogenic Escherichia coli encodes a vacuolating autotransporter toxin. Infect Immun. 2003;71(9):5087-5096.

[14] De Rycke J, Milon A, Oswald E. Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens. Vet Res. 1999;30(2-3):221-233.

[15] Nolan LK, Horne SM, Giddings CW, et al. Resistance to serum complement, iss, and virulence of avian Escherichia coli. Vet Res Commun. 2003;27(2):101-110.

[16] Jann K, Jann B. Capsules of Escherichia coli, expression and biological significance. Can J Microbiol. 1992;38(7):705-710.

[17] Blanco JE, Blanco M, Mora A, et al. Serotypes of Escherichia coli isolated from septicaemic chickens in Galicia (northwest Spain). Vet Microbiol. 1998;61(3):229-235.

[18] La Ragione RM, Cooley WA, Woodward MJ. The role of fimbriae and flagella in the adherence of avian pathogenic Escherichia coli O78:K80 to tissue culture cells and tracheal and gut explants. J Med Microbiol. 2000;49(4):327-338.

[19] Gross WB. Colibacillosis. In: Calnek BW, Barnes HJ, Beard CW, McDougald LR, Saif YM, eds. Diseases of Poultry. 10th ed. Iowa State University Press; 1997:138-144.

[20] Peighambari SM, Vaillancourt JP, Wilson RA, Gyles CL. Characteristics of Escherichia coli isolates from avian cellulitis. Avian Dis. 1995;39(1):116-124.

[21] Bisgaard M, Dam A. Salpingitis in poultry. I. Prevalence, bacteriology, and pathogenesis. Nord Vet Med. 1981;33(3):115-123.

[22] Harry EG. The effect on the developing chick of the presence of Escherichia coli in the incubator. Br Vet J. 1957;113:363-370.

[23] Markey B, Leonard F, Archambault M, Cullinane A, Maguire D. Clinical Veterinary Microbiology. 2nd ed. Mosby Elsevier; 2013.

[24] Orskov I, Orskov F. Escherichia coli serotyping and disease in man and animals. Can J Microbiol. 1992;38(7):699-704.

[25] Johnson TJ, Wannemuehler Y, Doetkott C, Johnson SJ, Rosenberger SC, Nolan LK. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol. 2008;46(12):3987-3996.

[26] Ewers C, Li G, Wilking H, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int J Med Microbiol. 2007;297(3):163-176.

[27] Chern EC, Siefring S, Paar J, Doolittle M, Haugland RA. Comparison of quantitative PCR assays for Escherichia coli targeting ribosomal RNA and single copy genes. Lett Appl Microbiol. 2011;52(3):298-306.

[28] Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5(1):58-65.

[29] Joensen KG, Tetzschner AM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol. 2015;53(8):2410-2426.

[30] Leitner G, Heller ED. Colonization of Escherichia coli in the respiratory tract of chickens: a study of the local immune response. Avian Dis. 1992;36(3):539-545.

[31] Gyles CL. Antimicrobial resistance in Escherichia coli. In: Aarestrup FM, ed. Antimicrobial Resistance in Bacteria of Animal Origin. ASM Press; 2006:123-144.

[32] Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53(6):2227-2238.

[33] Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009;22(1):161-182.

[34] Smet A, Martel A, Persoons D, et al. Broad-spectrum beta-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiol Rev. 2010;34(3):295-316.

[35] Shane SM. Colibacillosis in poultry: a review. Avian Dis. 1992;36(3):467-476.

[36] Deb JR, Harry EG. Laboratory trials with inactivated vaccines against Escherichia coli (O78 K80) infection in fowls. Res Vet Sci. 1976;20(2):131-138.

[37] Kwaga JK, Allan BJ, van den Hurk JV, Seida H, Potter AA. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infect Immun. 1994;62(9):3766-3772.

[38] Kariyawasam S, Wilkie BN, Gyles CL. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli. Avian Dis. 2004;48(2):287-299.

[39] Mellata M, Dho-Moulin M, Dozois CM, et al. Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. Infect Immun. 2003;71(1):536-540.

[40] Swayne DE, Suarez DL. Recombinant fowlpox virus vaccines for poultry. Dev Biol (Basel). 2003;114:155-164.

[41] Huff WE, Huff GR, Rath NC, Balog JM, Donoghue AM. Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poult Sci. 2005;84(4):655-659.

[42] Joerger RD. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult Sci. 2003;82(4):640-647.

[43] Patterson JA, Burkholder KM. Application of prebiotics and probiotics in poultry production. Poult Sci. 2003;82(4):627-631.

[44] Mountzouris KC, Tsirtsikos P, Kalamara E, Nitsch